LONDON BROKER RATINGS: Citi lifts Experian; Goldman Sachs cuts Ithaca
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 77.20p on 04-12-2025 at 10:25:15 |
|---|---|
| Change | 0.45p 0.59% |
| Buy | 77.40p |
| Sell | 77.10p |
| Last Trade: | Sell 224.00 at 77.25p |
| Day's Volume: | 176,726 |
| Last Close: | 76.75p |
| Open: | 80.35p |
| ISIN: | GB00BL6NGV24 |
| Day's Range | 76.45p - 80.35p |
| 52wk Range: | 43.94p - 100.80p |
| Market Capitalisation: | £746.02m |
| VWAP: | 77.12726p |
| Shares in Issue: | 966.35m |
Dr. Martens (DOCS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 224 | 77.25p | Automatic Execution |
10:20:19 - 04-Dec-25 |
| Buy* | 766 | 77.30p | Automatic Execution |
10:20:19 - 04-Dec-25 |
| Buy* | 10 | 77.342p | Ordinary |
10:12:24 - 04-Dec-25 |
| Sell* | 104 | 77.05p | Automatic Execution |
10:09:02 - 04-Dec-25 |
| Sell* | 3,092 | 76.95p | Automatic Execution |
10:08:11 - 04-Dec-25 |
| Sell* | 192 | 77.00p | Automatic Execution |
10:08:11 - 04-Dec-25 |
| Sell* | 71 | 77.00p | Automatic Execution |
10:08:11 - 04-Dec-25 |
| Sell* | 1,470 | 77.05p | Automatic Execution |
10:08:11 - 04-Dec-25 |
| Sell* | 530 | 77.05p | Automatic Execution |
10:08:11 - 04-Dec-25 |
| Sell* | 55 | 76.95p | SI Trade |
09:55:52 - 04-Dec-25 |
Dr. Martens (DOCS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Dec 2025 12:35 pm | RNS | Block listing Interim Review |
| 28th Nov 2025 11:58 am | RNS | Total Voting Rights |
| 25th Nov 2025 7:00 am | RNS | Holding(s) in Company |
| 20th Nov 2025 7:00 am | RNS | H1 FY26 Results |
| 12th Nov 2025 2:13 pm | RNS | Director/PDMR Shareholding |
| 31st Oct 2025 2:37 pm | RNS | Total Voting Rights |
| 21st Oct 2025 6:16 pm | RNS | Holding(s) in Company |
| 20th Oct 2025 4:06 pm | RNS | Holding(s) in Company |
| 16th Oct 2025 2:12 pm | RNS | Director/PDMR Shareholding |
| 14th Oct 2025 11:51 am | RNS | Director/PDMR Shareholding |